SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-001645
Filing Date
2023-02-21
Accepted
2023-02-21 16:35:37
Documents
133
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q aytu-20221231x10q.htm   iXBRL 10-Q 1967832
2 EX-31.1 aytu-20221231xex31d1.htm EX-31.1 15235
3 EX-31.2 aytu-20221231xex31d2.htm EX-31.2 14035
4 EX-32.1 aytu-20221231xex32d1.htm EX-32.1 14770
5 GRAPHIC aytu-20221231x10q001.jpg GRAPHIC 3651
  Complete submission text file 0001558370-23-001645.txt   11669933

Data Files

Seq Description Document Type Size
6 EX-101.SCH aytu-20221231.xsd EX-101.SCH 104679
7 EX-101.CAL aytu-20221231_cal.xml EX-101.CAL 83559
8 EX-101.DEF aytu-20221231_def.xml EX-101.DEF 363433
9 EX-101.LAB aytu-20221231_lab.xml EX-101.LAB 741657
10 EX-101.PRE aytu-20221231_pre.xml EX-101.PRE 657372
127 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20221231x10q_htm.xml XML 2407825
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 23648745
SIC: 2834 Pharmaceutical Preparations